4D Molecular Therapeutics, Inc. SEC filings FDMT
4D Molecular Therapeutics, Inc. has 439 filings in SEC EDGAR's recent list, going back to Aug 13, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 18, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 29, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 17, 2026 |
| EFFECT | Filing | May 13, 2026 | — |
| CORRESP | Letter to the SEC | May 11, 2026 | — |
| UPLOAD | Letter from the SEC | May 8, 2026 | — |
| S-3 | Shelf registration | May 7, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 30, 2026 | Mar 25, 2026 |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Jan 26, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 7, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Other events
|
Nov 7, 2025 | Nov 6, 2025 |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 31, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Oct 2, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 2, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 17, 2025 |
| S-8 | Employee stock plan registration | May 8, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 17, 2025 |
| EFFECT | Filing | Mar 24, 2025 | — |
| POS AM | Filing | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2025 | Feb 28, 2025 |
| POSASR | Filing | Feb 28, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 8, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Dec 11, 2024 | Dec 6, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 18, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2024 | Jul 23, 2024 |
| 8-K |
Current report
Other events
|
Jul 17, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 7, 2024 | Jun 7, 2024 |
| 424B5 | Prospectus supplement | Jun 7, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 10, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEF 14A | Proxy statement | Apr 10, 2024 | May 21, 2024 |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 9, 2024 | Feb 6, 2024 |
| 424B5 | Prospectus supplement | Feb 8, 2024 | — |
| FWP | Free writing prospectus | Feb 7, 2024 | — |
| 424B5 | Prospectus supplement | Feb 5, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 5, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jan 4, 2024 | Jan 1, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 22, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2023 | Sep 11, 2023 |
| EFFECT | Filing | Aug 15, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2023 | — |
| S-3 | Shelf registration | Aug 9, 2023 | — |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 11, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 10, 2023 |
| 8-K |
Current report
Other events
|
May 9, 2023 | May 4, 2023 |
| 424B5 | Prospectus supplement | May 8, 2023 | — |
| 424B5 | Prospectus supplement | May 4, 2023 | — |
| S-8 POS | Filing | May 4, 2023 | — |
| DEFA14A | Additional proxy material | Apr 12, 2023 | — |
| DEF 14A | Proxy statement | Apr 12, 2023 | May 23, 2023 |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Feb 3, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Other events
|
Jan 26, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2022 | Sep 23, 2022 |
| EFFECT | Filing | Sep 6, 2022 | — |
| CORRESP | Letter to the SEC | Sep 1, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2022 | — |
| S-3 | Shelf registration | Aug 23, 2022 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 21, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2022 | May 23, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| EFFECT | Filing | Apr 15, 2022 | — |
| CORRESP | Letter to the SEC | Apr 13, 2022 | — |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | May 23, 2022 |
| UPLOAD | Letter from the SEC | Apr 4, 2022 | — |
| S-3 | Shelf registration | Mar 29, 2022 | — |
| S-8 | Employee stock plan registration | Mar 28, 2022 | — |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2022 | Feb 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 424B4 | Prospectus | Nov 1, 2021 | — |
| EFFECT | Filing | Oct 28, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| S-1 | Registration statement | Oct 26, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 26, 2021 | Oct 25, 2021 |
| 8-K |
Current report
Other events
|
Oct 13, 2021 | Oct 10, 2021 |
| UPLOAD | Letter from the SEC | Oct 13, 2021 | — |
| DRS | Filing | Oct 8, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2021 | Sep 22, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Agreement ended, Other events
|
Jun 25, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2021 | May 17, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| DEFA14A | Additional proxy material | Apr 6, 2021 | — |
| DEF 14A | Proxy statement | Apr 6, 2021 | May 17, 2021 |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| S-8 | Employee stock plan registration | Dec 15, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Dec 15, 2020 | Dec 15, 2020 |
| 424B4 | Prospectus | Dec 14, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 11, 2020 | — |
| EFFECT | Filing | Dec 10, 2020 | — |
| S-1MEF | Filing | Dec 10, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 10, 2020 | — |
| CERT | Filing | Dec 10, 2020 | — |
| S-1/A | Amended registration statement | Dec 10, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| 8-A12B | Filing | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| S-1/A | Amended registration statement | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Nov 17, 2020 | — |
| S-1 | Registration statement | Nov 17, 2020 | — |
| DRS | Filing | Oct 14, 2020 | — |
| RW | Filing | Jul 21, 2020 | — |
| S-1 | Registration statement | Sep 30, 2019 | — |
| DRS/A | Filing | Aug 30, 2019 | — |
| DRS | Filing | Aug 2, 2019 | — |
| D | Filing | Sep 11, 2018 | — |
| D | Filing | Oct 19, 2015 | — |
| D | Filing | Aug 13, 2015 | — |
Showing 171 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- FDMT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1650648
- Former names
- 4D Molecular Therapeutics Inc. (until May 12, 2022); 4D Molecular Therapeutics Inc (until Sep 30, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.